BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 76938)

  • 1. Leucocyte adherence inhibition for detecting specific tumour immunity in early pancreatic cancer.
    Tataryn DN; MacFarlane JK; Thomson DM
    Lancet; 1978 May; 1(8072):1020-2. PubMed ID: 76938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
    Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
    Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
    [No Abstract]   [Full Text] [Related]  

  • 5. Automated leucocyte adherence inhibition testing in patients with colorectal cancer.
    McLeod DK; Isbister WH
    Immunol Cell Biol; 1987 Oct; 65 Pt 5():377-85. PubMed ID: 3325409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.
    Halliday WJ; Halliday JW; Campbell CB; Maluish AE; Powell LW
    Br Med J; 1974 May; 2(5915):349-52. PubMed ID: 4365124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
    MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
    Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on cell-mediated immunity in patients with colorectal cancer: leucocyte migration inhibition test using allogenic 3M KCl extract.
    Kojima O; Fujita Y; Iwai N; Yamane T; Kitagawa N; Nishioka B; Majima S
    Aust N Z J Surg; 1981 Oct; 51(5):434-9. PubMed ID: 6947781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract.
    Edgington TS; Astarita RW; Plow EF
    N Engl J Med; 1975 Jul; 293(3):103-7. PubMed ID: 166311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of cancers of colon, pancreas, stomach, and lung by automated tube leukocyte adherence inhibition assay.
    Tataryn DN; MacFarlane JK; Thomson DM
    Surg Forum; 1978; 29():130-2. PubMed ID: 401404
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of human leukocyte migration in agar by 3-M potassium chloride extracts of stomach, colon, and lung cancers.
    Iwaki J; Akagi M; Sairenji T; Hinuma Y
    J Natl Cancer Inst; 1979 Jul; 63(1):5-10. PubMed ID: 286834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
    Halliday WJ; Maluish A; Isbister WH
    Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
    Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
    Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancer.
    Douglass HO; Russo AJ; Howell JH; Moore MC; Arbuck SG; Chu TM; Goldrosen MH
    Cancer; 1979 Mar; 43(3):1084-8. PubMed ID: 371783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
    Zöller M; Matzku S; Schulz U; Price MR
    J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer concepts of cancer of the colon and rectum: cellular immunity to human colonic carcinomas.
    Hellström I; Hellström KE
    Dis Colon Rectum; 1972; 15(2):100-5. PubMed ID: 4554736
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.